This week's developments span office productivity, biomedical research and core EHR infrastructure. They are all called AI or AI-enabling technology, but they carry very different levels of clinical risk.
What practices should take from this
A useful portfolio separates assistance beside care from decisions about care. Drafting an internal policy or summarizing a meeting is not the same as suggesting a diagnosis. The data, oversight and evidence requirements should rise with the potential patient impact.
That does not mean administrative automation is trivial. Patient identity, protected information, tone, accuracy and escalation still matter. It means the practice can learn how to approve tools, train users and monitor results in a more controlled environment.
Build the governance muscle on work where errors are easy to detect. Then apply that discipline as the practice considers more consequential use cases.